We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Allegion
ALLE
$13B
| $1.89M | ﹤0.01% |
15,198
-3,565
| -19% | -$411K |
|
802
AptarGroup
ATR
$8.45B
| $1.89M | ﹤0.01% |
16,353
-4,307
| -21% | -$490K |
|
803
Nektar Therapeutics
NKTR
$2.39B
| $1.89M | ﹤0.01% |
5,841
-6
| -0.1% | -$1.74K |
|
804
Brighthouse Financial
BHF
$3.63B
| $1.88M | ﹤0.01% |
47,933
-50
| -0.1% | -$1.97K |
|
805
Invitation Homes
INVH
$17.7B
| $1.86M | ﹤0.01% |
62,128
+3,201
| +5% | +$96K |
|
|
BMY.RT
806
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $1.84M | ﹤0.01% |
+611,031
| New | +$1.59M |
|
807
Energy Transfer Partners
ET
$70.1B
| $1.83M | ﹤0.01% |
142,929
-117,690
| -45% | -$1.45M |
|
808
Curtiss-Wright
CW
$27.7B
| $1.83M | ﹤0.01% |
12,983
+275
| +2% | +$37.2K |
|
809
First Solar
FSLR
$21.8B
| $1.82M | ﹤0.01% |
32,498
+20
| +0.1% | +$1.1K |
|
810
Americold
COLD
$4.09B
| $1.82M | ﹤0.01% |
51,794
+3,381
| +7% | +$124K |
|
|
VRNT
811
DELISTED
Verint Systems
VRNT
| $1.81M | ﹤0.01% |
64,245
-6,739
| -9% | -$164K |
|
812
VanEck Agribusiness ETF
MOO
$989M
| $1.8M | ﹤0.01% |
26,210
| – | – |
|
813
Sasol
SSL
$7.58B
| $1.8M | ﹤0.01% |
83,323
-2,906
| -3% | -$55.6K |
|
814
CenterPoint Energy
CNP
$29.1B
| $1.78M | ﹤0.01% |
65,457
-18,047
| -22% | -$491K |
|
815
Vulcan Materials
VMC
$36.3B
| $1.78M | ﹤0.01% |
12,398
+561
| +5% | +$80.3K |
|
816
Chipotle Mexican Grill
CMG
$40.8B
| $1.78M | ﹤0.01% |
106,550
-14,150
| -12% | -$227K |
|
817
LKQ Corp
LKQ
$6.58B
| $1.77M | ﹤0.01% |
49,711
-14,842
| -23% | -$504K |
|
818
Northwest Natural Holdings
NWN
$2.17B
| $1.77M | ﹤0.01% |
23,994
+1,170
| +5% | +$80.8K |
|
819
America Movil
AMX
$78.1B
| $1.77M | ﹤0.01% |
110,385
+1,196
| +1% | +$18.7K |
|
820
Murphy Oil
MUR
$5.58B
| $1.77M | ﹤0.01% |
65,952
-3,723
| -5% | -$85.4K |
|
821
Atmos Energy
ATO
$29.9B
| $1.75M | ﹤0.01% |
15,643
-1,751
| -10% | -$192K |
|
822
ProShares Large Cap Core Plus
CSM
$509M
| $1.75M | ﹤0.01% |
45,292
+4,064
| +10% | +$150K |
|
823
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
| $1.75M | ﹤0.01% |
31,493
-4,815
| -13% | -$259K |
|
824
Teledyne Technologies
TDY
$30.4B
| $1.75M | ﹤0.01% |
5,039
-2,895
| -36% | -$973K |
|
825
Bio-Rad Laboratories Class A
BIO
$8.42B
| $1.74M | ﹤0.01% |
4,704
-5
| -0.1% | -$1.76K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.